Glycopeptide Antibacterial class drugs

5 results

  • firvanq

    (vancomycin hydrochloride)
    Azurity Pharmaceuticals, Inc
    FIRVANQ is indicated for treating Clostridium difficile-associated diarrhea and Staphylococcus aureus enterocolitis (including MRSA) in adults and pediatric patients under 18. It must be administered orally for these infections, and is not effective for other types of infections. Use should be judicious to prevent drug resistance.
    Medication Details
    Drug Interactions

  • vancocin

    (vancomycin hydrochloride)
    ANI Pharmaceuticals, Inc.
    VANCOCIN is indicated for treating Clostridioides difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including MRSA) in patients under 18. It must be administered orally for these infections, as parenteral use is ineffective. It's reserved for proven or suspected bacterial infections to prevent resistance.
    Medication Details
    Drug Interactions

  • vancomycin hydrochloride

    (vancomycin hydrochloride)
    Mylan Institutional LLC
    Vancomycin hydrochloride for injection is indicated for serious infections caused by methicillin-resistant staphylococci, effective in patients allergic to penicillin and in cases resistant to other antibiotics. It treats endocarditis, septicemia, and skin infections, and is administered orally for C. difficile-associated colitis. Use should be based on susceptibility data.
    Medication Details
    Drug Interactions

  • vancomycin hydrochloride

    (Vancomycin Hydrochloride)
    GLENMARK PHARMACEUTICALS INC., USA
    Vancomycin Hydrochloride for Injection is indicated for treating septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections caused by MRSA and other susceptible bacteria in adults and pediatric patients, including neonates. It should be used to prevent drug-resistant bacteria development.
    Medication Details
    Drug Interactions

  • vancomycin hydrochloride for oral solution

    (vancomycin hydrochloride)
    Wilshire Pharmaceuticals, Inc.
    Vancomycin hydrochloride is indicated for treating Clostridium difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including MRSA) in adults and pediatric patients under 18. It must be administered orally for these conditions and is ineffective for other infections when given parenterally.
    Medication Details
    Drug Interactions